Stephen Lam

Degrees / Designations 

MD, 1974, Medicine, University of Toronto
FRCPC, 1978, Internal Medicine & Respiratory Medicine, University of British Columbia

Email Address 
Mailing Address 
6112 - 675 W. 10th Avenue Vancouver, BC V5Z 1L3


Academic Appointment 
Disorders and Conditions 

Dr. Stephen Lam is a Professor of Medicine at the University of British Columbia. He chairs the Provincial Lung Tumor Group at the British Columbia Cancer Agency and directs the MDS-Rix Early Lung Cancer Detection and Translational Research Program at BCCA. His research interest is in early detection, chemoprevention and endoscopic therapy of lung cancer. He was the recipient of the Friesen-Rygiel Award for Outstanding Canadian Academic Discovery (1999), the Gustav Killian Medal by the World Association of Bronchology (2002) for his pioneering contributions to the field of early lung cancer diagnosis, the Distinguished Achievement Award from the University of British Columbia (2008) and the Joseph Cullen Award for life-time scientific achievements in lung cancer prevention research by the International Association for the Study of Lung Cancer (2009). Dr. Lam received his medical training at the University of Toronto and did his residency and fellowship training in Internal Medicine and Pulmonary Medicine at the University of British Columbia associated hospitals. After a post-doctoral fellowship at the Massachusetts General Hospital and the National Cancer Center Hospital in Tokyo, Japan, he joined the UBC Faculty of Medicine in 1979.

Current Projects 

Dr. Lam's research is in early detection and chemoprevention of lung cancer. In the late 1980’s and 1990s, he and his colleagues at BCCA developed autofluorescence bronchoscopy and other optical imaging methods such as optical coherence tomography and Raman Spectroscopy for localization and characterization of pre-neoplastic lesions and early lung cancer. The ability to localize and biopsy pre-invasive cancer has spurred international interest to study the natural history and molecular biology of pre-invasive lung cancer. He is currently the PI of the Pan-Canadian Early Detection of Lung Cancer Study involving eight centers across Canada from coast to coast. They have developed a web-based lung cancer risk prediction tool to identify smokers at sufficient risk for screening with low dose CT and to evaluate the incremental value of biomarkers. Very recently, they developed a highly accurate lung nodule malignancy risk calculator for screening CT detected lung nodules. He chairs the Canadian Partnership Against Cancer Expert Panel on Lung Cancer Screening and has published an on line document entitled, “Summary of Existing and New Evidence on Lung Cancer Screening”, to guide physicians and health care policy makers to make an informed decision on screening. He serves on the IASLC scientific advisory committee on lung cancer screening. Along with Dr. Victor Ling, has previously co-directed the first Genome Canada translational research team in lung cancer at the BC Cancer Agency. He is currently part of a consortium funded by DoD with Drs. Sam Hanash, David Gandara and Wan Lam to develop blood based biomarkers for early lung cancer detection and evaluation of CT detected lung nodules.